On the other hand, the age-associated increase in FGF21 levels is reminiscent of that occurring in obesity, suggesting that aging may be associated with a progressive loss of FGF21 responsiveness in tissues, giving rise to a reactive FGF21 up-regulation in a so-called “FGF21 resistance” scenario [10]. The gene discussed is FGF21; the disease is obesity disorder.